In just 4 weeks’ time, SMi's 21st Annual Superbugs & Superdrugs Conference will kick off in London, setting out to provide an international audience with key updates on the latest developments in combating antibiotic resistance, including the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.In the run up to the conference, SMi caught up with this year’s co-chair Lloyd Czaplewski, Director at Chemical Biology Ventures,... Source: RealWire
No comments:
Post a Comment